Seems to me the final ratio will be somewhere near
Post# of 147672
300 to 132 = 2.27 to 1
(1 or 2 of the 391 to 394th get placebo and 1 or 2 get leronlimab)
(Then, a bunch more getting leronlimab join in under the open label extension)
I almost gave up getting any info about the Winston-Salem, NC trial site. I was thinking that if I, my wife, or a friend got the virus, then we may go there.
Finally, I found some info. The person said I cannot be admitted based upon data from my hospital locally. I would have to travel (in severe/critical condition) to Novant Hospital in Winston-Salem, NC, be admitted as a patient, and then I would be evaluated for possible admission to the trial to get leronlimab.
Seems s/c patients are better off hoping to get leronlimab under the eIND program. When m/m, I will request invermectin per (Dr Yo and others and recent studies) and a steroid.
Some are predicting a very high % of Americans will get covid-19 by April/May/June when the vaccines are been widely administered and have produced immunity. Like, you and me are likely to become infected. We should each be making plans for m/m intervention and s/c intervention.
Similar situation, when leronlimab is approved, there will be a limited supply and thus a prioritizing as to who gets it first. And leronlimab may cure me, but 2 weeks later I could get infected again. Well... then hopefully I get more leronlimab again and the share price goes up a little more, a double dip.